Company profile for Lotte Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS is now entering the pharmaceutical industry as a CDMO company with the acquisition of Bristol-Myers Squibb’s Syracuse manufacturing site. By providing innovative medicines to patients, LOTTE BIOLOGICS aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. As one of the top-5 corporations in Korea, LOTT...
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS is now entering the pharmaceutical industry as a CDMO company with the acquisition of Bristol-Myers Squibb’s Syracuse manufacturing site. By providing innovative medicines to patients, LOTTE BIOLOGICS aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. As one of the top-5 corporations in Korea, LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE creates a sustainable future by continuously seeking out innovation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
LOTTE World Tower, 300 Olympic-ro, Songpa-gu, Seoul, Korea 05551
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251029483889/en/SK-pharmteco-and-LOTTE-BIOLOGICS-Sign-Strategic-Partnership-to-Strengthen-Global-ADC-CDMO-Capabilities

BUSINESSWIRE
29 Oct 2025

https://www.prnewswire.com/news-releases/lotte-biologics-establishes-contract-manufacturing-partnership-with-a-leading-us-biopharmaceutical-company-302543019.html

PR NEWSWIRE
02 Sep 2025

https://www.biospace.com/lotte-biologics-accelerates-global-cdmo-expansion-with-dual-manufacturing-bases-in-north-america-and-asia-and-next-generation-adc-modalities

BIOSPACE
04 Aug 2025

https://www.prnewswire.com/news-releases/lotte-biologics-signs-antibody-manufacturing-contract-with-ottimo-pharma-302485822.html

PR NEWSWIRE
20 Jun 2025

https://www.prnewswire.com/news-releases/lotte-biologics-to-present-at-the-2025-jp-morgan-healthcare-conference-302353767.html

PR NEWSWIRE
16 Jan 2025

https://www.prnewswire.com/news-releases/lotte-biologics-holds-groundbreaking-for-songdo-bio-campus-302189388.html

PR NEWSWIRE
03 Jul 2024

ABOUT THIS PAGE

Contact Lotte Biologics and get a quotation

Lotte Biologics is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Elotuzumab bulk offered by Lotte Biologics

Find a price of BELATACEPT bulk offered by Lotte Biologics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty